ES2194704T3 - Comprimido dispersable oralmente que presenta una debil friabilidad y su procedimiento de preparacion. - Google Patents

Comprimido dispersable oralmente que presenta una debil friabilidad y su procedimiento de preparacion.

Info

Publication number
ES2194704T3
ES2194704T3 ES00907743T ES00907743T ES2194704T3 ES 2194704 T3 ES2194704 T3 ES 2194704T3 ES 00907743 T ES00907743 T ES 00907743T ES 00907743 T ES00907743 T ES 00907743T ES 2194704 T3 ES2194704 T3 ES 2194704T3
Authority
ES
Spain
Prior art keywords
tablet
dispersable
presents
less
agent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES00907743T
Other languages
English (en)
Inventor
Costanzo Laurent Di
Edouard Andre Gendrot
Costanzo Mathieu Ernest Jea Di
Charles Andre Chauveau
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ethypharm SAS
Original Assignee
Ethypharm SAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9542663&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES2194704(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Ethypharm SAS filed Critical Ethypharm SAS
Application granted granted Critical
Publication of ES2194704T3 publication Critical patent/ES2194704T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Insulating Materials (AREA)
  • Lubricants (AREA)
  • Saccharide Compounds (AREA)

Abstract

Comprimido de desagregación rápida del tipo de los que están destinados a disgregarse en la boca en contacto con la saliva en menos de 30 segundos y formando una suspensión fácil de tragar y que está formado a base de una materia activa en forma de microcristales o microgránulos envueltos y de una mezcla de excipientes que comprenden por lo menos un agente de disgregación, un agente soluble y un agente lubrificante, caracterizado porque el agente lubrificante está en forma pulverulenta y se encuentra repartido por lo menos su mayor parte en la superficie del comprimido y porque su friabilidad, medida como se indica en la farmacopea francesa (X edición, ¿V.5.1-friabilidad de los comprimidos¿, enero 1993), es inferior a 1 %, preferentemente inferior a 0, 5 %, gracias a lo cual dicho comprimido puede ser acondicionado por medio de unos procedimientos estándar y presenta una dureza necesaria y suficiente para permitir su fácil extracción fuera del blister en el cual está acondicionado por perforación del opérculo de éste por el empuje del comprimido con un riesgo sustancialmente reducido de rotura en el momento de la extracción.
ES00907743T 1999-03-01 2000-02-29 Comprimido dispersable oralmente que presenta una debil friabilidad y su procedimiento de preparacion. Expired - Lifetime ES2194704T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9902516A FR2790387B1 (fr) 1999-03-01 1999-03-01 Comprime orodispersible presentant une faible friabilite et son procede de preparation

Publications (1)

Publication Number Publication Date
ES2194704T3 true ES2194704T3 (es) 2003-12-01

Family

ID=9542663

Family Applications (1)

Application Number Title Priority Date Filing Date
ES00907743T Expired - Lifetime ES2194704T3 (es) 1999-03-01 2000-02-29 Comprimido dispersable oralmente que presenta una debil friabilidad y su procedimiento de preparacion.

Country Status (16)

Country Link
US (1) US8377472B1 (es)
EP (1) EP1156786B1 (es)
JP (1) JP4969728B2 (es)
CN (1) CN1183903C (es)
AT (1) ATE235233T1 (es)
AU (1) AU771949B2 (es)
CA (1) CA2366027C (es)
DE (1) DE60001810T2 (es)
DK (1) DK1156786T3 (es)
ES (1) ES2194704T3 (es)
FR (1) FR2790387B1 (es)
HK (1) HK1039453B (es)
HU (1) HUP0200211A3 (es)
IL (2) IL145161A0 (es)
PT (1) PT1156786E (es)
WO (1) WO2000051568A1 (es)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8071128B2 (en) 1996-06-14 2011-12-06 Kyowa Hakko Kirin Co., Ltd. Intrabuccally rapidly disintegrating tablet and a production method of the tablets
US7815937B2 (en) 1998-10-27 2010-10-19 Biovail Laboratories International Srl Quick dissolve compositions and tablets based thereon
FR2824477B1 (fr) * 2001-05-09 2005-09-09 Ethypharm Lab Prod Ethiques Granules enrobes a base d'inhibiteur de l'enzyme de conversion de l'anfiotensine, leur procede de preparation et comprimes orodispersibles contenant les granules enrobes
EP1279402B1 (en) * 2001-07-26 2006-11-29 Ethypharm Coated granules of allylamine-or benzylamine-anti-mycotics, process for preparation thereof and orodispersible tablets containing said coated granules
US9358214B2 (en) 2001-10-04 2016-06-07 Adare Pharmaceuticals, Inc. Timed, sustained release systems for propranolol
FR2831820B1 (fr) * 2001-11-05 2004-08-20 Ethypharm Sa Comprime orodispersible presentant une grande homogeneite et son procede de preparation
US6723348B2 (en) 2001-11-16 2004-04-20 Ethypharm Orodispersible tablets containing fexofenadine
WO2004047793A1 (en) 2002-11-26 2004-06-10 Alk-Abelló A/S Pharmaceutical allergen product
US20040109889A1 (en) 2002-12-04 2004-06-10 Bunick Frank J. Surface treatment composition for soft substrates
US8367111B2 (en) 2002-12-31 2013-02-05 Aptalis Pharmatech, Inc. Extended release dosage forms of propranolol hydrochloride
EP1599185A1 (en) 2003-02-28 2005-11-30 Alk-Abello A/S Dosage form having a saccharide matrix
US8012505B2 (en) 2003-02-28 2011-09-06 Alk-Abello A/S Dosage form having a saccharide matrix
US8263126B2 (en) 2003-06-06 2012-09-11 Ethypharm Orally-dispersible multilayer tablet
CN1237981C (zh) * 2003-12-31 2006-01-25 北京科信必成医药科技发展有限公司 银杏叶口腔崩解片及其制备方法
US8545881B2 (en) 2004-04-19 2013-10-01 Eurand Pharmaceuticals, Ltd. Orally disintegrating tablets and methods of manufacture
US8747895B2 (en) 2004-09-13 2014-06-10 Aptalis Pharmatech, Inc. Orally disintegrating tablets of atomoxetine
US9884014B2 (en) 2004-10-12 2018-02-06 Adare Pharmaceuticals, Inc. Taste-masked pharmaceutical compositions
NZ589750A (en) 2004-10-21 2012-07-27 Aptalis Pharmatech Inc Taste-masked pharmaceutical compositions with gastrosoluble pore-formers
US9161918B2 (en) 2005-05-02 2015-10-20 Adare Pharmaceuticals, Inc. Timed, pulsatile release systems
AU2006299310A1 (en) 2005-10-04 2007-04-12 Alk-Abello A/S Solid vaccine formulation
WO2007050631A2 (en) * 2005-10-25 2007-05-03 Cima Labs Inc. Dosage form with coated active
US7811604B1 (en) 2005-11-14 2010-10-12 Barr Laboratories, Inc. Non-effervescent, orally disintegrating solid pharmaceutical dosage forms comprising clozapine and methods of making and using the same
EP2034953A4 (en) 2006-06-26 2013-05-15 Capricorn Pharma Inc ORAL DISINTEGRATING LAYER COMPOSITIONS
NZ574544A (en) 2006-08-04 2011-12-22 Ethypharm Sa Granule and orally disintegrating tablet comprising oxycodone
DK2046300T3 (da) 2006-08-04 2010-07-26 Ethypharm Sa Oralt desintegrerende multilagstablet
US20080085310A1 (en) * 2006-10-06 2008-04-10 Maria Oksana Bachynsky Capecitabine rapidly disintegrating tablets
WO2008089772A1 (fr) * 2007-01-22 2008-07-31 Crd Saidal Formulation d'un comprime orodispersible a base d'acide acetylsalicylique enrobe
JP5766899B2 (ja) * 2007-04-11 2015-08-19 ニプロ株式会社 口腔内崩壊剤及びその製造方法
CN101678012A (zh) * 2007-06-12 2010-03-24 阿尔克-阿贝洛有限公司 包含抗组胺药的过敏原剂型
EP2187926B1 (en) 2007-09-11 2012-01-25 Københavns Universitet Prevention of diabetes by administration of gliadin
CN101627972B (zh) * 2008-07-18 2010-12-22 齐鲁制药有限公司 恩替卡韦口腔崩解片及其制备方法
CN102958515A (zh) 2009-12-02 2013-03-06 阿普塔利斯制药有限公司 非索非那定微胶囊及含有非索非那定微胶囊的组合物
FR2962550B1 (fr) 2010-07-06 2013-06-14 Ethypharm Sa Methode pour lutter contre la soumission chimique, utilisation d'agent colorant pour lutter contre la soumission chimique et composition pharmaceutique permettant la mise en oeuvre de la methode
FR2962331B1 (fr) 2010-07-06 2020-04-24 Ethypharm Forme pharmaceutique pour lutter contre la soumission chimique, methode la mettant en oeuvre
EA201490500A1 (ru) * 2011-08-30 2014-06-30 Университейт Гент Многослойный высвобождающий состав
EP2952200A1 (en) 2014-06-04 2015-12-09 Alk-Abelló A/S Allergen for prophylactic treatment of allergy
JP6128160B2 (ja) * 2015-05-07 2017-05-17 ニプロ株式会社 口腔内崩壊錠の製造方法

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4292017A (en) 1980-07-09 1981-09-29 Doepel Wallace A Apparatus for compressing tablets
US4684534A (en) * 1985-02-19 1987-08-04 Dynagram Corporation Of America Quick-liquifying, chewable tablet
GB8530365D0 (en) 1985-12-10 1986-01-22 Univ Bath Manufacture of moulded products
FR2679451B1 (fr) 1991-07-22 1994-09-09 Prographarm Laboratoires Comprime multiparticulaire a delitement rapide.
US5464632C1 (en) 1991-07-22 2001-02-20 Prographarm Lab Rapidly disintegratable multiparticular tablet
DE4318577A1 (de) * 1993-06-04 1994-12-08 Merck Patent Gmbh Schmiermittelfreie, arzneimittelhaltige Tabletten
JP2681601B2 (ja) 1993-11-01 1997-11-26 協和醗酵工業株式会社 外部滑沢式打錠機
ATE253899T1 (de) * 1994-01-31 2003-11-15 Yamanouchi Pharma Co Ltd Intraoral löslicher formpressling und verfahren zu seiner herstellung
JP2917799B2 (ja) * 1994-03-11 1999-07-12 田辺製薬株式会社 消化管内適所放出型製剤
DE4412117A1 (de) 1994-04-08 1995-10-12 Fette Wilhelm Gmbh Verfahren und Vorrichtung zum Aufbringen von pulverförmigem Schmier- oder Trennmittel auf die Preßwerkzeuge in Tablettiermaschinen
US6391337B2 (en) * 1995-11-15 2002-05-21 Edward Mendell Co., Inc. Directly compressible high load acetaminophen formulations
JP3797387B2 (ja) 1996-06-14 2006-07-19 協和醗酵工業株式会社 口腔内速崩壊錠
JP3708291B2 (ja) 1996-06-21 2005-10-19 協和醗酵工業株式会社 微量粉体吐出装置及びこの装置を用いた微量粉体噴霧方法
DE19647089A1 (de) * 1996-11-14 1998-05-28 Bayer Ag Vorrichtung zum kontrollierten Aufsprühen von pulverförmigen Schmiermitteln auf Stempel und Matrizen von Tablettenpressen
FR2766089B1 (fr) 1997-07-21 2000-06-02 Prographarm Lab Comprime multiparticulaire perfectionne a delitement rapide
US6465009B1 (en) * 1998-03-18 2002-10-15 Yamanouchi Pharmaceutical Co., Ltd. Water soluble polymer-based rapidly dissolving tablets and production processes thereof
EP1070497A4 (en) 1998-04-10 2009-01-21 Kyowa Hakko Kogyo Kk Tablet manufacturing methods and tablet
FR2785538B1 (fr) 1998-11-06 2004-04-09 Prographarm Laboratoires Comprime a delitement rapide perfectionne

Also Published As

Publication number Publication date
FR2790387A1 (fr) 2000-09-08
AU2922400A (en) 2000-09-21
JP4969728B2 (ja) 2012-07-04
HK1039453B (zh) 2003-11-14
WO2000051568A1 (fr) 2000-09-08
PT1156786E (pt) 2003-08-29
IL145161A0 (en) 2002-06-30
IL145161A (en) 2006-08-01
HK1039453A1 (en) 2002-04-26
CA2366027A1 (fr) 2000-09-08
CA2366027C (fr) 2012-04-10
CN1183903C (zh) 2005-01-12
AU771949B2 (en) 2004-04-08
ATE235233T1 (de) 2003-04-15
DE60001810D1 (de) 2003-04-30
EP1156786A1 (fr) 2001-11-28
HUP0200211A3 (en) 2006-07-28
HUP0200211A2 (en) 2002-06-29
FR2790387B1 (fr) 2001-05-18
EP1156786B1 (fr) 2003-03-26
CN1342067A (zh) 2002-03-27
JP2003506316A (ja) 2003-02-18
US8377472B1 (en) 2013-02-19
DE60001810T2 (de) 2004-02-05
DK1156786T3 (da) 2003-07-14

Similar Documents

Publication Publication Date Title
ES2194704T3 (es) Comprimido dispersable oralmente que presenta una debil friabilidad y su procedimiento de preparacion.
AR018143A1 (es) Formulacion para preparar un comprimido de desintegracion rapida, comprimidos de desintegracion rapida, especialmente comprimidos de desintegracionrapida en la boca
ES2414084T3 (es) Sistema de administración de fármacos por vía transmucosa
Thakur et al. Overview “a novel approach of fast dissolving films and their patients”
ES2236617T3 (es) Comprimido orodispersable que presenta una gran homogeneidad y su procedimiento de preparacion.
WO2009071219A2 (en) Oral dispersable tablet
AR024384A1 (es) UNA FORMA DE DOSIFICACIoN FARMACÉUTICA DE DISOLUCIoN INSTANTÁNEA Y UN MÉTODO PARA PREPARARLA
ES2167921T3 (es) Comprimido multiparticular perfeccionado de disgregacion rapida.
ES2046214T3 (es) Medicamento con liberacion retardada de la sustancia activa.
DE69739967D1 (de) Eine im Mund schnell zerfallende Tablette
MXPA05007643A (es) Metodo para producir una forma farmaceutica oral con desintegracion inmediata y liberacion de ingrediente activo.
MX2009000730A (es) Liberacion controlada de formulaciones y metodos asociados.
CR7661A (es) Composicion de comprimido de liberacion sostenida de pramipexol
MXPA01004518A (es) Tableta de rapida desintegracion mejorada..
PT1131050E (pt) Formulacoes galenicas que se desintegram rapidamente na boca e metodo para as preparar
ES2982524T3 (es) Comprimido de disgregación por vía oral
US7201922B2 (en) Orodispersible solid pharmaceutical form
Hoffmann et al. Ultra–fast disintegrating ODTs comprising viable probiotic bacteria and HPMC as a mucoadhesive
ES2130081B1 (es) Comprimido de maleato de trimebutina con recubrimiento laminar.
MY137516A (en) Pharmaceutical composition comprising lumiracoxib
DK1517677T3 (da) Poppende oral administrationsform
MXPA06000332A (es) Nueva composicion farmaceutica solida que comprende amisulprida.
AR023138A1 (es) Composicion para gomas de mascar medicadas, proceso de fabricacion y tabletas obtenidas con dicho proceso
Nasreen et al. Mouth dissolving tablets-A unique dosage form curtailed for special purpose: a review
WO2007016350A3 (en) Modified release tablet formulations with enhanced mechanical properties